Aptevo Therapeutics announces special shareholder meeting
APVO•Special shareholder meeting scheduled
Aptevo Therapeutics will hold a virtual special stockholder meeting on Sept. 22, 2026.
Votes are set on an amended and restated certificate of incorporation, including the Series A Junior Participating Preferred Stock designation.
Shareholder authorization is sought for issuance tied to Inducement Warrants and Common Warrants, enabling potential exercise for common stock.
Approval is also sought for the Fifth Amended and Restated 2018 Stock Incentive Plan, adding 180,000 shares for equity awards.
Stockholders will also vote on a proposal to adjourn the meeting if more time is needed to secure votes.
